These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10667619)

  • 1. Evidence-based psychopharmacology 2. Appraising a systematic review: is risperidone better than conventional antipsychotics in the treatment of schizophrenia?
    Warner JP
    J Psychopharmacol; 1999 Dec; 13(4):415-8. PubMed ID: 10667619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews.
    Melnik T; Soares BG; Puga ME; Atallah AN
    Sao Paulo Med J; 2010 May; 128(3):141-66. PubMed ID: 20963366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine versus other atypical antipsychotics for schizophrenia.
    Asenjo Lobos C; Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Leucht S
    Cochrane Database Syst Rev; 2010 Nov; (11):CD006633. PubMed ID: 21069690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
    Temmingh HS; Williams T; Siegfried N; Stein DJ
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone versus typical antipsychotic medication for schizophrenia.
    Hunter RH; Joy CB; Kennedy E; Gilbody SM; Song F
    Cochrane Database Syst Rev; 2003; (2):CD000440. PubMed ID: 12804396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggression and schizophrenia: efficacy of risperidone.
    Buckley PF; Ibrahim ZY; Singer B; Orr B; Donenwirth K; Brar PS
    J Am Acad Psychiatry Law; 1997; 25(2):173-81. PubMed ID: 9213289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New generation antipsychotics for first episode schizophrenia.
    Rummel C; Hamann J; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziprasidone versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; Bhoopathi PS; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006627. PubMed ID: 19821380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone (depot) for schizophrenia.
    Sampson S; Hosalli P; Furtado VA; Davis JM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertindole versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; Schmidt F; Lewis R; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006752. PubMed ID: 19370652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A discussion of 2 double-blind studies comparing risperidone and quetiapine in patients with schizophrenia.
    Gharabawi GM; Bossie CA; Pandina GJ; Kujawa MJ; Greenspan AJ; Zhu Y
    J Clin Psychiatry; 2007 Feb; 68(2):333; author reply 334. PubMed ID: 17335334
    [No Abstract]   [Full Text] [Related]  

  • 17. Amisulpride versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Silveira da Mota Neto JI; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD006624. PubMed ID: 20091599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
    Huang MW; Gibson RC; Jayaram MB; Caroff SN
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013100. PubMed ID: 35844143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based pharmacotherapy of schizophrenia.
    Emsley R; Oosthuizen P
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):219-38. PubMed ID: 15043765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.